The ECHO program will help support and greatly expand the utilization of a number of synergistic existing childhood longitudinal cohort studies at different sites, including ITMI's Childhood Longitudinal Cohort Study, which began accrual in July 2012.
"I am extremely excited to be part of this national effort to better understand how we as individuals, the life choices we make, and our environment impact our development as newborns and our future wellness," said Dr. Niederhuber. "This was my vision when I came to Inova and initiated the Childhood Longitudinal Cohort. If you want to understand behavior, neurologic development and the earliest stages of progression toward disease, then you must start at the beginning."
Dr. Niederhuber has led the ongoing collaborations with the Mount Sinai team since 2014 and serves as the Principle Investigator for the ECHO sub-award to ITMI. Other partners in the Mt. Sinai consortium ECHO award include Harvard, Ben Gurion University, Columbia University, the University of North Carolina and Northwestern University. Of this group, ITMI has the largest cohort of families and newborns being actively followed, with over 3000 families enrolled over the past four years. The grant award greatly expands the research efforts of the existing ITMI cohort.
Inova is a not-for-profit healthcare system based in Northern Virginia that serves more than 2 million people each year throughout the Washington, DC, metro area and beyond. Inova is a comprehensive network of hospitals, outpatient services and facilities, primary and specialty care practices, and health and wellness initiatives.
Inova encompasses the full array of health services, including the area's only Level 1 Trauma Center and Level 4 neonatal intensive care unit. We are home to many nationally and internationally recognized programs, including Inova Heart and Vascular Institute (IHVI), Inova Translational Medicine Institute (ITMI), Inova Schar Cancer Institute (ISCI).
Inova is a global leader in the science of genomics and the new era of personalized health, which uses a person's genetic make-up, family and medical history, and lifestyle to determine the best prevention and treatment. We connect researchers, clinicians and empowered consumers to improve patient care, enhance prevention and encourage wellness.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/inova-translational-medicine-institute-receives-95-million-award-from-nih-to-study-environmental-influences-on-child-health-300337416.html